Results 171 to 180 of about 31,546 (261)

Randomized Controlled Clinical Trial Comparing Screw‐Retained Monolithic Zirconia Implant Crowns on Standardized Titanium Base Versus Customized Titanium Abutments– 3‐Years Data

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To assess 3‐year interim results of implant‐supported monolithic zirconia single crowns on standardized titanium base vs. customized titanium abutments. Material and Methods Patients in need of posterior implant were recruited.
Jenni Hjerppe   +5 more
wiley   +1 more source

Antibiotic Prophylaxis and Surgical Site Infections in Septoplasty

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Background Surgical site infection is one of the most common complications of septoplasty. The use of antibiotic prophylaxis has been debated for years. Since the practice at our centre has shifted towards a more frequent use of prophylactic antibiotics in septoplasties, our aim was to review its use and effect on the postoperative infection ...
Sara Sainio   +5 more
wiley   +1 more source

Consensus Report of Group 1 of the 1st Global Consensus for Clinical Guidelines for the Rehabilitation of the Edentulous Maxilla: Number of Implants, Timing of Implant Placement and Loading. [PDF]

open access: yesClin Oral Implants Res
Donos N   +27 more
europepmc   +1 more source

Cutaneous candidal infection caused by <i>Yarrowia lipolytica</i> in an immunocompetent patient. [PDF]

open access: yesJAAD Case Rep
Küçük K   +4 more
europepmc   +1 more source

The Suppurative Panniculitis of the Breast

open access: yesThe Breast Journal, 2015
Mustafa, Emiroglu   +5 more
openaire   +2 more sources

Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy